Epidemiology of invasive fungal diseases in patients with hematological malignancies and haematopoietic cell transplantation recipients: Systematic review and meta-analysis of trends over time

Background: Invasive fungal diseases (IFD) are severe complications in patients with hematological malignancies, worsening prognosis, and increasing mortality. Despite extensive research, epidemiological data often lack temporal systematization, hindering interpretation and practical application. Th...

Full description

Saved in:
Bibliographic Details
Main Authors: Marina Popova, Yuliya Rogacheva
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:Journal of Infection and Public Health
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1876034125001534
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849421089332002816
author Marina Popova
Yuliya Rogacheva
author_facet Marina Popova
Yuliya Rogacheva
author_sort Marina Popova
collection DOAJ
description Background: Invasive fungal diseases (IFD) are severe complications in patients with hematological malignancies, worsening prognosis, and increasing mortality. Despite extensive research, epidemiological data often lack temporal systematization, hindering interpretation and practical application. The objective was to assess the incidence and etiology of IFDs in oncohematological patients across different therapeutic groups using published studies. Methods: A systematic search was conducted in PubMed (Medline), Embase, and Google Scholar. Meta-analyses using primarily random-effects models were performed to estimate IFD incidence, overall etiological structure (proportions of major genera like Aspergillus, Candida, and rare pathogens), and analyze temporal trends (pre- vs. post-2010). Results: Incidence analysis included 34 publications (47 cohorts; 91,151 participants); etiology analysis included 35 cohorts (4427 isolates). Pooled IFD incidence was significantly higher in allo-HSCT recipients (9.96 %, 95 % CI 8.24–11.83 %) compared to chemotherapy (5.22 %, 95 % CI 3.96–6.65 %) and auto-HSCT (3.39 %, 95 % CI 1.56–5.83 %). Overall, Aspergillus (44.8 %) and Candida (34.1 %) dominated IFD etiology. A numerical shift occurred over time, with Candida proportion (48.6 %) surpassing Aspergillus (38.0 %) after 2010, reversing the pattern seen before 2010 (Candida 30.0 %, Aspergillus 47.8 %). Rare pathogens collectively accounted for ∼12.9 % pre-2010 and ∼8.8 % post-2010. Despite these numerical shifts, no statistically significant overall differences in IFD incidence or the proportions of major/rare pathogen groups were found between the pre- and post-2010 periods based on subgroup difference tests (p > 0.05). Etiology varied significantly by treatment. Conclusion: This comprehensive meta-analysis reveals significant variability in IFD incidence and etiology based on treatment modality, with allo-HSCT conferring the highest risk. While numerical shifts in pathogen distribution occurred over time, statistically significant overall temporal trends were not detected in this dataset for major or rare pathogens. High study heterogeneity is a key limitation. The findings underscore the need for risk-stratified prophylaxis and diagnostics, informing antifungal stewardship strategies tailored to treatment settings.
format Article
id doaj-art-97824fb93e4e42cc8dc6b682f86afada
institution Kabale University
issn 1876-0341
language English
publishDate 2025-08-01
publisher Elsevier
record_format Article
series Journal of Infection and Public Health
spelling doaj-art-97824fb93e4e42cc8dc6b682f86afada2025-08-20T03:31:33ZengElsevierJournal of Infection and Public Health1876-03412025-08-0118810280410.1016/j.jiph.2025.102804Epidemiology of invasive fungal diseases in patients with hematological malignancies and haematopoietic cell transplantation recipients: Systematic review and meta-analysis of trends over timeMarina Popova0Yuliya Rogacheva1RM Gorbacheva Research Institute, Pavlov University, Ulitsa Rentgena, 12, St. Petersburg, 197022, Russia; Correspondence to: L'va Tolstogo str. 6-8, Saint-Petersburg, Russia, 197022.RM Gorbacheva Research Institute, Pavlov University, Ulitsa Rentgena, 12, St. Petersburg, 197022, RussiaBackground: Invasive fungal diseases (IFD) are severe complications in patients with hematological malignancies, worsening prognosis, and increasing mortality. Despite extensive research, epidemiological data often lack temporal systematization, hindering interpretation and practical application. The objective was to assess the incidence and etiology of IFDs in oncohematological patients across different therapeutic groups using published studies. Methods: A systematic search was conducted in PubMed (Medline), Embase, and Google Scholar. Meta-analyses using primarily random-effects models were performed to estimate IFD incidence, overall etiological structure (proportions of major genera like Aspergillus, Candida, and rare pathogens), and analyze temporal trends (pre- vs. post-2010). Results: Incidence analysis included 34 publications (47 cohorts; 91,151 participants); etiology analysis included 35 cohorts (4427 isolates). Pooled IFD incidence was significantly higher in allo-HSCT recipients (9.96 %, 95 % CI 8.24–11.83 %) compared to chemotherapy (5.22 %, 95 % CI 3.96–6.65 %) and auto-HSCT (3.39 %, 95 % CI 1.56–5.83 %). Overall, Aspergillus (44.8 %) and Candida (34.1 %) dominated IFD etiology. A numerical shift occurred over time, with Candida proportion (48.6 %) surpassing Aspergillus (38.0 %) after 2010, reversing the pattern seen before 2010 (Candida 30.0 %, Aspergillus 47.8 %). Rare pathogens collectively accounted for ∼12.9 % pre-2010 and ∼8.8 % post-2010. Despite these numerical shifts, no statistically significant overall differences in IFD incidence or the proportions of major/rare pathogen groups were found between the pre- and post-2010 periods based on subgroup difference tests (p > 0.05). Etiology varied significantly by treatment. Conclusion: This comprehensive meta-analysis reveals significant variability in IFD incidence and etiology based on treatment modality, with allo-HSCT conferring the highest risk. While numerical shifts in pathogen distribution occurred over time, statistically significant overall temporal trends were not detected in this dataset for major or rare pathogens. High study heterogeneity is a key limitation. The findings underscore the need for risk-stratified prophylaxis and diagnostics, informing antifungal stewardship strategies tailored to treatment settings.http://www.sciencedirect.com/science/article/pii/S1876034125001534invasive fungal diseasesrare invasive fungal diseasesrare moldsrare yeastsHSCTsystematic review
spellingShingle Marina Popova
Yuliya Rogacheva
Epidemiology of invasive fungal diseases in patients with hematological malignancies and haematopoietic cell transplantation recipients: Systematic review and meta-analysis of trends over time
Journal of Infection and Public Health
invasive fungal diseases
rare invasive fungal diseases
rare molds
rare yeasts
HSCT
systematic review
title Epidemiology of invasive fungal diseases in patients with hematological malignancies and haematopoietic cell transplantation recipients: Systematic review and meta-analysis of trends over time
title_full Epidemiology of invasive fungal diseases in patients with hematological malignancies and haematopoietic cell transplantation recipients: Systematic review and meta-analysis of trends over time
title_fullStr Epidemiology of invasive fungal diseases in patients with hematological malignancies and haematopoietic cell transplantation recipients: Systematic review and meta-analysis of trends over time
title_full_unstemmed Epidemiology of invasive fungal diseases in patients with hematological malignancies and haematopoietic cell transplantation recipients: Systematic review and meta-analysis of trends over time
title_short Epidemiology of invasive fungal diseases in patients with hematological malignancies and haematopoietic cell transplantation recipients: Systematic review and meta-analysis of trends over time
title_sort epidemiology of invasive fungal diseases in patients with hematological malignancies and haematopoietic cell transplantation recipients systematic review and meta analysis of trends over time
topic invasive fungal diseases
rare invasive fungal diseases
rare molds
rare yeasts
HSCT
systematic review
url http://www.sciencedirect.com/science/article/pii/S1876034125001534
work_keys_str_mv AT marinapopova epidemiologyofinvasivefungaldiseasesinpatientswithhematologicalmalignanciesandhaematopoieticcelltransplantationrecipientssystematicreviewandmetaanalysisoftrendsovertime
AT yuliyarogacheva epidemiologyofinvasivefungaldiseasesinpatientswithhematologicalmalignanciesandhaematopoieticcelltransplantationrecipientssystematicreviewandmetaanalysisoftrendsovertime